Foff Erin Pennock reported grant involving 54,240 derivative units of MapLight Therapeutics, Inc. at $0.00 for $0 on Aug 17, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Medical Officer
Chief Medical Officer
Filed Aug 19, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
54,240Employee Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
54,240Direct
Trade date
Aug 17, 2026Grant
Filed
Aug 19, 2026, 6:35 PM ET2-day reporting delay
Accession
0002021233-26-000014Code A · Transaction 12070
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 17, 2026Grant13,360$0.00$0Trade 12069
2 transaction rows in this filing. Joint filers share the same rows.

MPLT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MPLT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +212%1w ago +0.2%1d ago −3.3%
Returns since7d +5.8%30d −10%90d180d1y

Footnotes in full

F1: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date. F2: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. F3: 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.